NYSEMKT:CATX

Perspective Therapeutics Stock Forecast

etoro logo Buy CATX
*Your capital is at risk
$2.95
-0.270 (-8.39%)
At Close: Jul 16, 2026
AI Analysis AI Analysis of CATX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CATX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Perspective Therapeutics, Inc. stock price fell more than -8.39% Thursday closing at $2.95
(Updated on Jul 16, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026

The Perspective Therapeutics, Inc. stock price fell by -8.39% on the last day (Thursday, 16th Jul 2026) from $3.22 to $2.95. During the last trading day the stock fluctuated 9.97% from a day low at $2.91 to a day high of $3.20. The price has fallen in 7 of the last 10 days and is down by -14.74% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -103 thousand shares and in total, 1 million shares were bought and sold for approximately $3.76 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.30% during the next 3 months and, with a 90% probability hold a price between $1.69 and $2.46 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CATX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Perspective Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.13 and $3.25. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -18.73%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Perspective Therapeutics, Inc. stock

Perspective Therapeutics, Inc. finds support from accumulated volume at $2.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 9.97%. For the last week, the stock has had daily average volatility of 8.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CATX) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Perspective Therapeutics, Inc. to open at $3.02, and during the day (based on 14 day Average True Range), to move between $2.83 and $3.07, which gives a possible trading interval of +/-$0.245 (+/-8.67%) up or down from last closing price. If Perspective Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.94 (0.34%) than the resistance at $3.00 (1.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Perspective Therapeutics, Inc. stock A Buy?

Perspective Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -4.333 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $3.02 ( 2.37%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CATX Performance

Trading levels for CATX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.31 12.20%
R2 3.20 8.45%
R1 3.13 6.13%
Price 2.95
S1 2.91 -1.38%
S2 2.84 -3.70%
S3 2.73 -7.46%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.60 22.03%
R2 3.04 3.05%
R1 3.00 1.69%
Price 2.95
S1 2.94 -0.339%
S2 2.93 -0.678%
S3 0 -

FAQ

What is the symbol for Perspective Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Perspective Therapeutics, Inc. is CATX and it is traded on the NYSEMKT (NYSE American).

Should I buy or sell Perspective Therapeutics, Inc. Stock?
Perspective Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Perspective Therapeutics, Inc. Stock?
Perspective Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Perspective Therapeutics, Inc. Stock.

What's the current price of Perspective Therapeutics, Inc. Stock?
As of the end of day on the Jul 16, 2026, the price of an Perspective Therapeutics, Inc. (CATX) share was $2.95.

What is the 52-week high and low for Perspective Therapeutics, Inc. Stock?
The 52-week high for Perspective Therapeutics, Inc. Stock is $6.16 and the 52-week low is $1.96.

What is the market capitalization of Perspective Therapeutics, Inc. Stock?
As of the Jul 16, 2026, the market capitalization of Perspective Therapeutics, Inc. is 227.888M.

When is the next earnings date for Perspective Therapeutics, Inc.?
The upcoming earnings date for Perspective Therapeutics, Inc. is Aug 12, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE